Ocugen Inc (OCGN)
0.9058
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
0.9058
0.00 (0.00%)
After-Hours: 16:51
Ocugen Total Assets (Quarterly): 61.94M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 61.94M |
| June 30, 2024 | 40.54M |
| March 31, 2024 | 51.79M |
| December 31, 2023 | 64.55M |
| September 30, 2023 | 74.69M |
| June 30, 2023 | 88.98M |
| March 31, 2023 | 96.30M |
| December 31, 2022 | 108.63M |
| September 30, 2022 | 116.24M |
| June 30, 2022 | 130.09M |
| March 31, 2022 | 141.73M |
| December 31, 2021 | 105.76M |
| September 30, 2021 | 116.31M |
| June 30, 2021 | 124.25M |
| March 31, 2021 | 53.85M |
| December 31, 2020 | 27.38M |
| September 30, 2020 | 20.54M |
| June 30, 2020 | 23.76M |
| March 31, 2020 | 12.31M |
| December 31, 2019 | 16.81M |
| September 30, 2019 | 23.62M |
| June 30, 2019 | 3.20M |
| Date | Value |
|---|---|
| March 31, 2019 | 14.84M |
| December 31, 2018 | 17.43M |
| September 30, 2018 | 10.88M |
| June 30, 2018 | 15.15M |
| March 31, 2018 | 21.32M |
| December 31, 2017 | 11.04M |
| September 30, 2017 | 15.83M |
| June 30, 2017 | 22.13M |
| March 31, 2017 | 28.31M |
| December 31, 2016 | 36.08M |
| September 30, 2016 | 42.80M |
| June 30, 2016 | 21.28M |
| March 31, 2016 | 28.52M |
| December 31, 2015 | 36.79M |
| September 30, 2015 | 45.30M |
| June 30, 2015 | 53.24M |
| March 31, 2015 | 61.58M |
| December 31, 2014 | 65.50M |
| September 30, 2014 | 13.00M |
| June 30, 2014 | 14.84M |
| December 31, 2013 | 14.80M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
12.31M
Minimum
Mar 2020
141.73M
Maximum
Mar 2022
73.82M
Average
69.62M
Median
Total Assets (Quarterly) Benchmarks
| Cytokinetics Inc | 1.436B |
| Scholar Rock Holding Corp | 179.13M |
| Mirum Pharmaceuticals Inc | 667.89M |
| SpringWorks Therapeutics Inc | 608.88M |
| NeuroBo Pharmaceuticals Inc | 22.15M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.31M |
| Shareholders Equity (Quarterly) | 40.63M |
| Debt to Equity Ratio | 0.0711 |
| Current Ratio | 2.580 |
| Net Debt Paydown Yield | -0.01% |